Meyers Michael L. 4
4 · Syndax Pharmaceuticals Inc · Filed Feb 5, 2021
Insider Transaction Report
Form 4
Meyers Michael L.
SVP, Chief Development Officer
Transactions
- Other
Common Stock
2020-07-31$7.97/sh+2,665$21,240→ 13,395 total - Other
Common Stock
2021-01-31$12.00/sh+1,771$21,252→ 15,166 total - Award
Stock Option (Right to Buy)
2021-02-03+80,000→ 80,000 totalExercise: $21.36Exp: 2031-02-03→ Common Stock (80,000 underlying)
Footnotes (3)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 2,665 shares by the Reporting Person on 07/31/2020 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,771 shares by the Reporting Person on 01/31/2021 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]1/48th of the shares subject to the option shall vest monthly over a four-year period.